2nd October 2024 – (Hong Kong) The Centre for Health Protection (CHP) of the Department of Health (DH) announced today, 2nd October, that it is investigating a confirmed case of Mpox, commonly known as Monkeypox, involving a 43-year-old man. The CHP has urged the public to exercise heightened vigilance and to avoid close physical contact with individuals suspected of having the virus. High-risk groups are particularly encouraged to receive Mpox vaccinations.
The patient, who has a history of good health, developed a skin rash on September 24. He sought medical attention at the Wan Chai Male Social Hygiene Clinic on 25th and 27th September and is currently in stable condition, having been admitted to Princess Margaret Hospital.
According to the patient, he had travelled to Thailand and Taiwan during the incubation period and was exposed to high-risk situations in both locations. Initial investigations have not revealed any epidemiological links between this case and previously confirmed cases in Hong Kong. The CHP is continuing its epidemiological investigations and will report the case to the World Health Organization.
The CHP has reiterated its advice for high-risk groups to get vaccinated against Mpox to reduce the risk of infection and the severity of symptoms if infected. Individuals experiencing Mpox symptoms—such as rashes, fever, chills, swollen lymph nodes, fatigue, muscle pain, and severe headaches—are urged to seek immediate medical attention. They should refrain from activities that may expose others to their skin rashes or bodily fluids.
In addition, the public is encouraged to maintain good personal hygiene practices to prevent the transmission of the virus and to avoid close contact with individuals or animals suspected of being infected.
